Literature DB >> 879319

Mechanism of angiotensin II-induced proteinuria in the rat.

M P Bohrer, W M Deen, C R Robertson, B M Brenner.   

Abstract

To investigate the mechanism(s) of angiotensin II-induced proteinuria, polydisperse [3H]dextran (D) (radius = 18-42 A) was infused into seven Munich-Wistar rats before and during intravenous infusion of angiotensin II (AII), 0.35 microgram/kg per min. During AII infusion, UprotV rose approximately twofold, and the fractional clearances of D [(U/P)D/(U/P)In] increased significantly for dextrans with radii greater than 22 A. Single nephron filtration fraction increased, due to a measured rise in the glomerular transcapillary hydraulic pressure difference from 34 to 43 mmHg. Near constancy of single nephron glomerular filtration rate resulted, however, from the offsetting effect of a decrease in glomerular plasma flow rate from 83 to 60 nl/min. These measured hemodynamic changes were found, by the use of pore theory, to account to a large extent for the measured increases in (U/P)D/(U/P)In. In seven other rats, fractional clearances of polyanionic dex-ran sulfate (a more reliable marker of albumin filtration than D) were also found to increase significantly with AII, suggesting that the proteinuria induced by AII can be explained, in large part, by hemodynamic factors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879319     DOI: 10.1152/ajprenal.1977.233.1.F13

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  33 in total

1.  A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension.

Authors:  O Samuelsson; T Hedner; S Ljungman; H Herlitz; B Widgren; K Pennert
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Angiotensin converting enzyme inhibition reduces proteinuria in Nigerians with chronic renal disease.

Authors:  A A Ajayi; A T Ajayi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.

Authors:  E Hommel; H H Parving; E Mathiesen; B Edsberg; M Damkjaer Nielsen; J Giese
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

4.  Dynamic structure of glomerular capillary loop as revealed by an in vivo cryotechnique.

Authors:  S Ohno; N Terada; Y Fujii; H Ueda; I Takayama
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

5.  Modulation of cyclic nucleotides in islated rat glomeruli: role of histamine, carbamylcholine, parathyroid hormone, and angiotensin-II.

Authors:  V E Torres; T E Northrup; R M Edwards; S V Shah; T P Dousa
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

6.  Injured Podocytes Are Sensitized to Angiotensin II-Induced Calcium Signaling.

Authors:  Julia Binz-Lotter; Christian Jüngst; Markus M Rinschen; Sybille Koehler; Peter Zentis; Astrid Schauss; Bernhard Schermer; Thomas Benzing; Matthias J Hackl
Journal:  J Am Soc Nephrol       Date:  2020-01-10       Impact factor: 10.121

7.  Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.

Authors:  María Gracia Caletti; Alejandro Balestracci; Mabel Missoni; Clarisa Vezzani
Journal:  Pediatr Nephrol       Date:  2012-12-20       Impact factor: 3.714

8.  Predominant functional roles for thromboxane A2 and prostaglandin E2 during late nephrotoxic serum glomerulonephritis in the rat.

Authors:  K Takahashi; G F Schreiner; K Yamashita; B W Christman; I Blair; K F Badr
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

9.  Glomerular epithelial cell changes after ischemia or dehydration. Possible role of angiotensin II.

Authors:  L C Racusen; D H Prozialeck; K Solez
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

10.  Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans.

Authors:  A Guasch; W M Deen; B D Myers
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.